Advertisement
New Zealand markets closed
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NZD/USD

    0.5934
    -0.0000 (-0.01%)
     
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • OIL

    82.81
    -0.55 (-0.66%)
     
  • GOLD

    2,328.90
    -13.20 (-0.56%)
     

Pfizer: Analysts Expect Revenue Growth in Q3

Pfizer: Analysts Expect Revenue Growth in Q3

As we discussed earlier, analysts expect Pfizer’s (PFE) revenues to be ~$13.5 billion in the third quarter—which is ~2.8% growth compared to revenues of $13.2 billion during the third quarter of 2017. The revenue growth is expected to be driven by innovative health products’ strong performance.